Emory University to begin HIV vaccine trials in October
BY Advocate.com Editors
September 27 2002 12:00 AM ET
Human trials of an HIV vaccine that aims to prompt immune system responses to virus inside the body will begin in October at Atlanta's Emory University, where the vaccine was developed, The Atlanta Journal-Constitution reports. The vaccine consists of two injections of compounds crafted from HIV genes--the first primes the body to produce an antibody response to invading virus, and a second shot activates the body's natural killer cells, which attack cells infected with HIV. The clinical trials, which will involve about 30 volunteers, will begin in early October. Preliminary results aren't expected until late 2003.
- Mormon Missionary Positions
- Charles Barkley: Move Final Four Out of Indiana
- 12 Celebrities Who Said the “F” Word
- Tim Cook on Standing Up to Discrimination: 'It’s Time for All of Us'
- The Only 2 Things to Know Out of Mike Pence's Dissembling Interview
- Time to #BoycottIndiana? Celebs Blow Up Social Media